Bcl-xL Cancer Research Results
Bcl-xL, Bcl-xL: Click to Expand ⟱
| Source: |
| Type: pro-survival proteins |
The proteins of BCL-2 family are classified into three subgroups, i.e., the anti-apoptotic/pro-survival proteins represented by BCL-2 and BCL-XL.
BCL-XL overexpressing cells exhibited higher tumors sphere formation capacity and expressed higher levels of some stem cell markers, supporting the concept that BCL-XL plays essential roles in the maintenance of cancer stem cell phenotype.
|
AML, Acute Myeloid Leukemia: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
STAT3↓, cycD1/CCND1↓, Bcl-2↓, Bcl-xL↓, survivin↓, VEGF↓, TumCCA↑, Apoptosis↑, Casp↑, eff↑,
| - |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vivo, |
AML, |
NA |
|
|
|
TumCP↓, Apoptosis↑, TumCG↓, PDK1 / PDPK1↓, cl‑PARP↑, Bcl-xL↓, Bcl-2↓, Beclin-1/ATG6↓, ATG3↓, PI3K↓, Akt↓, eff↑,
TumCG↓, TumCCA↑, Apoptosis↑, P53↑, P21↑, BAX↑, PUMA↑, NOXA↑, APAF1↑, NF-kB↓, IAP1↓, Bcl-xL↓, Bcl-2↓, XIAP↓, Myc↓, ChemoSen↑, Casp9↑, cl‑PARP↑, eff↑,
Apoptosis↑, Diff↑, tumCV↓, TumCP↓, MMP↓, BAX↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, Cyt‑c↑, cl‑Casp3↑, cl‑Casp9↑, cl‑PARP↑, p‑MEK↑, p‑ERK↑, ROS↑, eff↓,
| - |
in-vitro, |
AML, |
NA |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
DNMT1↓, Sp1/3/4↓, NF-kB↓, Apoptosis↑, Casp↑, Bcl-xL↓, COX2/PTGS2↓, iNOS↓, 5LO↓, TNF-α↓, cycD1/CCND1↓, BioAv↝, TumCG↓,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
p‑MEK↑, 1, MMP↓, 1, XIAP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
PDK1 / PDPK1↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, APAF1↑, 1, Apoptosis↑, 5, BAX↑, 2, Bcl-2↓, 4, Bcl-xL↓, 5, Casp↑, 2, cl‑Casp3↑, 1, Casp9↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 1, IAP1↓, 1, iNOS↓, 1, Mcl-1↓, 1, Myc↓, 1, NOXA↑, 1, PUMA↑, 1, survivin↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Sp1/3/4↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG3↓, 1, Beclin-1/ATG6↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNMT1↓, 1, P53↑, 1, cl‑PARP↑, 3,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 2, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Diff↑, 1, p‑ERK↑, 1, PI3K↓, 1, STAT3↓, 1, TumCG↓, 3,
Migration(tgid=13) ⓘ
5LO↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, NF-kB↓, 2, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, ChemoSen↑, 1, eff↓, 1, eff↑, 3,
Clinical Biomarkers(tgid=22) ⓘ
Myc↓, 1,
Total Targets: 49
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Bcl-xL, Bcl-xL
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:2 Cells:% prod#:% Target#:28 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page